Literature DB >> 7790821

Triglyceride-rich lipoproteins prevent septic death in rats.

T E Read1, C Grunfeld, Z L Kumwenda, M C Calhoun, J P Kane, K R Feingold, J H Rapp.   

Abstract

Triglyceride-rich lipoproteins bind and inactive bacterial endotoxin in vitro and prevent death when given before a lethal dose of endotoxin in animals. However, lipoproteins have not yet been demonstrated to improve survival in polymicrobial gram-negative sepsis. We therefore tested the ability of triglyceride-rich lipoproteins to prevent death after cecal ligation and puncture (CLP) in rats. Animals were given bolus infusions of either chylomicrons (1 g triglyceride/kg per 4 h) or an equal volume of saline for 28 h after CLP. Chylomicron infusions significantly improved survival (measured at 96 h) compared with saline controls (80 vs 27%, P < or = 0.03). Chylomicron infusions also reduced serum levels of endotoxin, measured 90 min (26 +/- 3 vs 136 +/- 51 pg/ml, mean +/- SEM, P < or = 0.03) and 6 h (121 +/- 54 vs 1,026 +/- 459 pg/ml, P < or = 0.05) after CLP. The reduction in serum endotoxin correlated with a reduction in serum tumor necrosis factor, measured 6 h after CLP (0 +/- 0 vs 58 +/- 24 pg/ml, P < or = 0.03), suggesting that chylomicrons improve survival in this model by limiting macrophage exposure to endotoxin and thereby reducing secretion of inflammatory cytokines. Infusions of a synthetic triglyceride-rich lipid emulsion (Intralipid; KabiVitrum, Inc., Alameda, CA) (1 g triglyceride/kg) also significantly improved survival compared with saline controls (71 vs 27%, P < or = 0.03). These data demonstrate that triglyceride-rich lipoproteins can protect animals from lethal polymicrobial gram-negative sepsis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790821      PMCID: PMC2192094          DOI: 10.1084/jem.182.1.267

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  Identification of the trypanocidal factor in normal human serum: high density lipoprotein.

Authors:  M R Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

3.  An improved chromogenic substrate endotoxin assay for clinical use.

Authors:  R I Harris; P C Stone; J Stuart
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

4.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

5.  Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.

Authors:  B J Owens; G M Anantharamaiah; J B Kahlon; R V Srinivas; R W Compans; J P Segrest
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

6.  Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6.

Authors:  C Grunfeld; S Adi; M Soued; A Moser; W Fiers; K R Feingold
Journal:  Cancer Res       Date:  1990-07-15       Impact factor: 12.701

7.  Chylomicrons enhance endotoxin excretion in bile.

Authors:  T E Read; H W Harris; C Grunfeld; K R Feingold; M C Calhoun; J P Kane; J H Rapp
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

8.  Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.

Authors:  J S Patton; H M Shepard; H Wilking; G Lewis; B B Aggarwal; T E Eessalu; L A Gavin; C Grunfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

9.  Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro.

Authors:  G J Darlington; D R Wilson; L B Lachman
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

10.  The metabolism of chylomicron cholesteryl ester in rat liver. A combined radioautographic-electron microscopic and biochemical study.

Authors:  O Stein; Y Stein; D S Goodman; N H Fidge
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

View more
  17 in total

1.  Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines.

Authors:  Behzad Kasravi; Diana H Lee; Jean W Lee; Stephen Dada; Hobart W Harris
Journal:  J Surg Res       Date:  2007-07-30       Impact factor: 2.192

Review 2.  Of microbes and meals: the health consequences of dietary endotoxemia.

Authors:  Caleb J Kelly; Sean P Colgan; Daniel N Frank
Journal:  Nutr Clin Pract       Date:  2012-02-29       Impact factor: 3.080

3.  Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice.

Authors:  M G Netea; P N Demacker; N de Bont; O C Boerman; A F Stalenhoef; J W van der Meer; B J Kullberg
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Lipoprotein(a) inhibits lipopolysaccharide-induced tumor necrosis factor alpha production by human mononuclear cells.

Authors:  M G Netea; N de Bont; P N Demacker; B J Kullberg; L E Jacobs; T J Verver-Jansen; A F Stalenhoef; J W Van der Meer
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Heart failure and statins--why do we need a clinical trial?

Authors:  M Böhm; A Hjalmarson; J Kjekshus; U Laufs; J McMurray; D J van Veldhuisen
Journal:  Z Kardiol       Date:  2005-04

6.  Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins.

Authors:  R L Kitchens; P A Thompson; S Viriyakosol; G E O'Keefe; R S Munford
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 7.  NKT cells in sepsis.

Authors:  Briana Leung; Hobart W Harris
Journal:  Clin Dev Immunol       Date:  2010-10-04

Review 8.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  Enteral administration of high-fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial translocation.

Authors:  Misha D P Luyer; Jan A Jacobs; Anita C E Vreugdenhil; M'hamed Hadfoune; Cornelis H C Dejong; Wim A Buurman; Jan Willem M Greve
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969

10.  Cholesterol improves the utilization of parenteral lipid emulsions.

Authors:  Wilfred Druml; Margot Fischer
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.